Deficiência de fosfofrutoquinase
Revisado por Dr Hayley Willacy, FRCGP Última atualização por Dr Colin Tidy, MRCGPÚltima atualização 21 Abr 2023
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Versão em Áudio
Profissionais de Saúde
Os artigos de Referência Profissional são projetados para uso por profissionais de saúde. Eles são escritos por médicos do Reino Unido e baseados em evidências de pesquisa, diretrizes do Reino Unido e da Europa. Você pode encontrar um dos nossos artigos de saúde mais útil.
Neste artigo:
Synonyms: Tarui's disease, glycogen storage disease type VII, muscle phosphofructokinase deficiency
Continue lendo abaixo
What is phosphofructokinase deficiency?
Phosphofructokinase (PFK) deficiency is a glycogen storage disorder (GSD). It is rare and is inherited as an autosomal recessive disorder. There is a mutation in the gene encoding muscle PFK on chromosome 12.1
There is also reduced activity of red cell PFK. The main clinical features include exercise intolerance, muscle cramping, exertional myopathy, compensated haemolysis and myoglobinuria.1 There are three subtypes:
Infantile-onset (a few rare cases have been reported).
Classic (most common).
Late-onset.
What is phosphofructokinase? (Pathophysiology)
Voltar ao conteúdoPFK is needed for glycolysis. The enzyme deficiency results in the accumulation of glycogen in the tissues. The enzyme deficiency can also lead to increased uric acid production and therefore possible gota. There may be a compensated haemolytic anaemia.
PFK has muscle, liver and platelet subunits. In muscle tissue, it is only composed of muscle subunits but erythrocyte PFK is composed of both muscle and liver subunits. This means that in classic PFK deficiency, there is no PFK activity in muscle and about 50% activity in erythrocytes.
Continue lendo abaixo
How common is phosphofructokinase deficiency? (Epidemiology)
Voltar ao conteúdoIt is very rare and has been reported in approximately 100 patients worldwide.2
The overall incidence of glycogen storage disorders is estimated as 1 per 20,000-43,000 live births.3
Symptoms may be mild in some people so there may be some cases that go unrecognised.
Males appear to be affected more commonly than females.
It is more common in Ashkenazi Jews.1
Phosphofructokinase deficiency symptoms (presentation)4
Voltar ao conteúdoInfantile-onset form2
The cases reported have presented under the age of 1 year.
Clinical features can include myopathy, psychomotor impairment, cataracts and joint contractures.
Death usually occurs during childhood.
There is a 2007 case report of a boy with PFK deficiency who presented, aged 3 days, with neonatal seizures and early infantile non-progressive muscle weakness. He was gaining in his developmental milestones and his seizures were controlled on medication.5
Classic form
Symptoms are usually first noticed in childhood.
There is exercise intolerance with muscle pain, easy muscle fatigue, weakness and stiffness. Symptoms improve with rest.
Nausea and vomiting can occur after exercise.
If exercise intensity is increased, severe muscle cramps can occur.
Myoglobinuria can occur after intense exercise. This can (rarely) lead to acute kidney injury.
A compensated haemolysis may also be present and can lead to haemolytic anaemia and sometimes jaundice.
Physical examination may be normal.
Gallstones (due to raised bilirubin) and gout may be other clinical features.
Neurological symptoms have been reported in one case study, including complex partial seizures, diplopia, hyporeflexia, central facial palsy, and upper extremity weakness. The same patient had cardiac involvement (supraventricular tachycardia, thickened mitral valve, mitral valve insufficiency, enlarged left atrium, left ventricular hypertrophy, and diastolic dysfunction).6
Late-onset form
This presents in adults as progressive muscle and limb weakness without cramps or myoglobinuria.
Continue lendo abaixo
Diagnóstico diferencial
Voltar ao conteúdoSymptoms may be similar to McArdle's glycogen storage disease but more severe.
Consider other causes of muscle weakness and myoglobinuria.
Investigações4
Voltar ao conteúdoExames de sangue:
Serum creatine kinase is usually raised.
Fasting glucose: hypoglycaemia.
Uric acid: hyperuricaemia.
Bilirubin may be elevated; check LFTs (liver failure may occur).
FBC can show anaemia with a raised reticulocyte count.
Monitor renal function tests if myoglobinuria is present.
Urinalysis:
There may be myoglobinuria after exercise.
Imaging and electrophysiology:
Cortical atrophy and ventricular dilatation may be seen on brain imaging in the infantile form.
Electromyography (EMG) may show changes consistent with myopathy or may be normal.
Muscle biopsy:
Assay of PFK in muscle tissue shows reduced levels and can give a definitive diagnosis.
Phosphofructokinase deficiency treatment4
Voltar ao conteúdoNo specific treatment exists.
The patient (or parents/carers) should be given information about the disorder and advised to avoid high-carbohydrate meals, as they can exacerbate exercise intolerance.
A healthy diet should be encouraged. There is evidence that a high-protein diet may improve muscle function and slow progression of the disease.
One study found a long-term effect of a ketogenic diet, with an improvement of muscle symptoms, breathing, exercise performance and oxygen uptake.7
Anaerobic exercise should be avoided.
Renal function should be monitored.
Aconselhamento genético should be offered. Prenatal detection may be possible in families with identifiable mutations.
Terapia genética may be possible for the future.
Complicações
Voltar ao conteúdoMyoglobinuria and (rarely) lesão renal aguda.
Haemolysis and icterícia.
Gota.
Cardiomiopatia and heart valve involvement.6
Prognóstico
Voltar ao conteúdoThe infantile variant generally has a very poor prognosis with death in infancy and early childhood.2
However there is a case report of a boy with PFK deficiency who presented when 3 days old with neonatal seizures and early infantile non-progressive muscle weakness but went on to attain normal developmental milestones and his seizures were controlled on medication.5
The prognosis for the other variants is usually very good but weakness and stiffness invariably appear in muscle groups subjected to vigorous or prolonged exertion.3
Leitura adicional e referências
- Associação para Doenças de Armazenamento de Glicogênio do Reino Unido
- Stone WL, Basit H, Adil A; Doença de Armazenamento de Glicogênio. StatPearls, maio de 2023.
- Glycogen storage disease VII, GSD7; Herança Mendeliana Online no Homem (OMIM)
- Toscano A, Musumeci O; Tarui disease and distal glycogenoses: clinical and genetic update. Acta Myol. 2007 Oct;26(2):105-7.
- Ozen H; Doenças de armazenamento de glicogênio: Novas perspectivas. World J Gastroenterol. 14 de maio de 2007;13(18):2541-53.
- Musumeci O, Bruno C, Mongini T, et al; Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). Neuromuscul Disord. 2012 Apr;22(4):325-30. doi: 10.1016/j.nmd.2011.10.022. Epub 2011 Nov 30.
- Al-Hassnan ZN, Al Budhaim M, Al-Owain M, et al; Muscle phosphofructokinase deficiency with neonatal seizures and nonprogressive course. J Child Neurol. 2007 Jan;22(1):106-8.
- Finsterer J, Stollberger C; Progressive mitral valve thickening and progressive muscle cramps as manifestations of glycogenosis VII (Tarui's Disease). Cardiology. 2008;110(4):238-40. Epub 2007 Dec 12.
- Simila ME, Auranen M, Piirila PL; Beneficial Effects of Ketogenic Diet on Phosphofructokinase Deficiency (Glycogen Storage Disease Type VII). Front Neurol. 2020 Feb 4;11:57. doi: 10.3389/fneur.2020.00057. eCollection 2020.
Continue lendo abaixo
Histórico do artigo
As informações nesta página são escritas e revisadas por clínicos qualificados.
Próxima revisão prevista para: 19 Abr 2028
21 Abr 2023 | Última versão

Pergunte, compartilhe, conecte-se.
Navegue por discussões, faça perguntas e compartilhe experiências em centenas de tópicos de saúde.

Sentindo-se mal?
Avalie seus sintomas online gratuitamente